WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Website Development Wednesday, September 9, 2026 
Add Press Release News | News Feeds Feeds | Email This News Email


FDAnews Announces -- Get Your Combination Products to Market Faster: Comply with the Latest Legal and Regulatory Developments Webinar Oct. 29, 2020
Friday, October 23, 2020

Get combination products to market faster when you get a handle on the recent legal and regulatory developments. Register today.

FALLS CHURCH, Va., Oct. 15, 2020 /PRNewswire-PRWeb/ -- Want to get combination products to market faster? Considering premarket submissions like 510(k), De Novo or premarket approval (PMA)?

One must adhere to a wave of legal and regulatory developments from the FDA's Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH). One must assess and comply with the drug patent and exclusivity provisions that now apply to drug-device combination products.

Three specialists from the FDA and Life Sciences practice of King & Spalding's Washington, D.C. office are here help you do just that. Chris Markus, Esq. is a partner, Jessica Ringel, Esq. is counsel, and Quynh Hoang is a senior regulatory consultant.

They'll provide tips for evaluating and addressing the new drug patent and exclusivity provisions. They will guide attendees on this new, potentially unfamiliar requirement by explaining the process and identifying resources, which can help ensure one is providing the appropriate responses and information to meet the new requirements and get products on the way to approval. Their updates will include:

    --  Key resources for drug patent and exclusivity information, including the
        FDA's Orange Book and other online CDER resources
    --  Key considerations in confirming the duration of patents and
        exclusivity, such as additive pediatric exclusivity or patent term
        extensions
    --  Timelines and milestones in the patent certification process, including
        certification to FDA, direct notifications to new drug applications
        (NDAs) and patent holders and their effect on clearance/approval
        timelines
    --  Interactions with the drug patent holder when needed, including
        notifications and rights of reference
    --  Information to include in the marketing submission to CDRH, such as
        Paragraph IV certification and confirmation of notifications

Knowledge is power and knowledge of the recent legal and regulatory developments impacting combination products means the power to comply and get them to market faster.

Interested in registering multiple sites?
Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
to learn about our special multisite discount.

Webinar Details:
Get Your Combination Products to Market Faster:
Comply with the Latest Legal and Regulatory Developments
An FDAnews Webinar
Thursday, Oct. 29, 2020, 1:30 p.m.-3:00 p.m. EDT
https://www.fdanews.com/combinationproductsfaster

Tuition:
$287 per site

Easy Ways to Register:
Online: https://www.fdanews.com/combinationproductsfaster
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

SOURCE FDAnews



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Asetek - Mandatory Notification of Trade | Jan 22, 2026
Nav Tomorrowland Brings the Magic to Shanghai for a Spectacular First Indoor Edition in China | Jan 22, 2026
Nav BC.GAME to Host "Stay Untamed" Night During Abu Dhabi's Packed Web3 Summit Week | Jan 22, 2026
Nav Auburn University's Applied Research Institute Expands Advanced Manufacturing Capabilities with CF3D Enterprise Cell | Jan 22, 2026
Nav Rent Manager Earned Best Real Estate Software Product Award and Multiple Review Badges from G2 Platform | Jan 22, 2026
Nav California Divorce Mediation Center Unveils Modern Website Redesign | Jan 22, 2026
Nav AMPERA ANNOUNCES LOCATION FOR GLOBAL HEADQUARTERS | Jan 22, 2026
Nav Culture and tourism sectors thrive in Xiamen | Jan 22, 2026
Nav Immutable Announces First Co-Founder-Hosted Live Webinar: How to Dominate Your Steam Launch | Jan 22, 2026
Nav StackGen Named in Four Gartner® Hype Cycles(TM) for Platform Engineering, Infrastructure Strategy, Site Reliability Engineering, and I&O Automation in 2025 | Jan 22, 2026
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News